End-of-life care in patients with primary malignant brain tumors: Early is better

Neuro-Oncology

Volumn 18, Issue 1, 2016, Pages 7-8

  Walbert, Tobias ^a   Pace, Andrea ^b  

^a HENRY FORD HOSPITAL   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANXIETY; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DEPRESSION; DISEASE CONTROL; EARLY INTERVENTION; EDITORIAL; HEALTH CARE NEED; HEALTH CARE QUALITY; HOSPICE CARE; HUMAN; ILLNESS TRAJECTORY; NEUROLOGIC DISEASE; PATIENT CARE; PATIENT CARE PLANNING; PATIENT REFERRAL; PRIMARY TUMOR; PSYCHOSOCIAL CARE; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; SYMPTOM; TERMINAL CARE; BRAIN TUMOR;

BRAIN NEOPLASMS; HUMANS; TERMINAL CARE;

EID: 84960430576     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov241     Document Type: Editorial

References (17)

1. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742.
2. Amano K, Morita T, Tatara R, et al. Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life. J Palliat Med. 2015; 18(3):270-273.
3. Bergman J, Saigal CS, Lorenz KA, et al. Hospice use and high-intensity care in men dying of prostate cancer. Arch Int Med. 2011;171(3):204-210.
4. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14): 1665-1673.
5. Prigerson HG, Bao Y, Shah MA, et al. Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol. 2015;1(6):778-784.
6. Sizoo EM, Pasman HR, Dirven L, et al. The end-of-life phase of high-grade glioma patients: a systematic review. Support Care Cancer. 2014;22(3):847-857.
7. Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol. 2014;117(2):217-224.
8. Walbert T, Puduvalli VK, Taphoorn MJ, et al. International patterns of palliative care in neuro-oncology: a survey of physician members of the Asian Society for Neuro-Oncology, the European Association of Neuro-Oncology, and the Society for Neuro-Oncology. Neuro-Oncol Pract. 2015;2:62-69.
9. Flechl B, Ackerl M, Sax C, et al. The caregivers perspective on the end-of-life phase of glioblastoma patients. J Neurooncol. 2013; 112(3):403-411.
10. Koekkoek JA, Dirven L, Reijneveld JC, et al. End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol. 2014;120(2):303-310.
11. Koekkoek JA, Dirven L, Sizoo EM, et al. Symptoms and medication management in the end of life phase of high-grade glioma patients. J Neuro-oncol. 2014;120(3):589-595.
12. Minaya Flores P, Berbis J, Chinot O, et al. Assessing the quality of life among caregivers of patients with gliomas. Neurooncol Pract. 2014;1(4):191-197.
13. Pace A, Villani V, Di Pasquale A, et al. Home care for brain tumor patients. Neurooncol Pract. 2014;1(1):8-12.
14. Pompili A, Telera S, Villani V, et al. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients. Neurosurg Foc. 2014; 37(6):E5.
15. Sizoo EM, Pasman HRW, Buttolo J, et al. Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer. 2012;48(2):226-232.
16. Sizoo EM, Taphoorn MJ, Uitdehaag B, et al. The end-of-life phase of high-grade glioma patients: Dying with dignity?. Oncologist. 2013; 18(2):198-203.
17. Phillips J, Walbert T. Quality of life and symptoms in terminal high-grade glioma (S18.005). Neurology. 2015;84(14):Suppl S18.005.